Diagnostics & Research stocks
28 Diagnostics & Research companies worth $1B or more: the 10 highest-scored first, then all of them by size. The median scores 60/100 as of Nov 19, 2026. Each score is 80% fundamentals, judged against Healthcare companies rather than the whole market, and 20% technicals. Another 8 smaller Diagnostics & Research companies are scored in the app.
Highest-scored Diagnostics & Research stocks
| Company | Industry | Market cap | Score |
|---|---|---|---|
| MEDP Medpace | Diagnostics & Research | $17.7B | 69 |
| IDXX IDEXX Laboratories | Diagnostics & Research | $54.3B | 66 |
| DGX Quest Diagnostics | Diagnostics & Research | $28.5B | 64 |
| VCYT Veracyte | Diagnostics & Research | $2.0B | 64 |
| A Agilent Technologies | Diagnostics & Research | $49.4B | 63 |
| LH Labcorp | Diagnostics & Research | $30.0B | 63 |
| QGEN Qiagen | Diagnostics & Research | $10.2B | 63 |
| SHC Sotera Health Company | Diagnostics & Research | $4.6B | 63 |
| WAT Waters | Diagnostics & Research | $89.7B | 63 |
| MTD Mettler-Toledo International | Diagnostics & Research | $33.9B | 63 |
All 28 Diagnostics & Research stocks by market cap
| Company | Industry | Market cap | Score |
|---|---|---|---|
| TMO Thermo Fisher Scientific | Diagnostics & Research | $255.2B | 61 |
| DHR Danaher | Diagnostics & Research | $160.1B | 60 |
| WAT Waters | Diagnostics & Research | $89.7B | 63 |
| IDXX IDEXX Laboratories | Diagnostics & Research | $54.3B | 66 |
| A Agilent Technologies | Diagnostics & Research | $49.4B | 63 |
| NTRA Natera | Diagnostics & Research | $42.0B | 56 |
| IQV IQVIA | Diagnostics & Research | $41.3B | 61 |
| MTD Mettler-Toledo International | Diagnostics & Research | $33.9B | 63 |
| ILMN Illumina | Diagnostics & Research | $30.3B | 63 |
| LH Labcorp | Diagnostics & Research | $30.0B | 63 |
| DGX Quest Diagnostics | Diagnostics & Research | $28.5B | 64 |
| GH Guardant Health | Diagnostics & Research | $19.7B | 57 |
| MEDP Medpace | Diagnostics & Research | $17.7B | 69 |
| RVTY Revvity | Diagnostics & Research | $16.9B | 59 |
| CRL Charles River Laboratories International | Diagnostics & Research | $15.7B | 58 |
| ICLR ICON Public Limited Company | Diagnostics & Research | $14.3B | 59 |
| QGEN Qiagen | Diagnostics & Research | $10.2B | 63 |
| RDNT RadNet | Diagnostics & Research | $5.5B | 53 |
| GRAL GRAIL | Diagnostics & Research | $4.7B | 48 |
| SHC Sotera Health Company | Diagnostics & Research | $4.6B | 63 |
| ADPT Adaptive Biotechnologies | Diagnostics & Research | $4.5B | 55 |
| CDNA CareDx | Diagnostics & Research | $3.8B | 59 |
| VCYT Veracyte | Diagnostics & Research | $2.0B | 64 |
| NEO NeoGenomics | Diagnostics & Research | $2.0B | 51 |
| PSNL Personalis | Diagnostics & Research | $1.6B | 45 |
| WGS GeneDx Holdings | Diagnostics & Research | $1.5B | 50 |
| OPK OPKO Health | Diagnostics & Research | $1.2B | 33 |
| CSTL Castle Biosciences | Diagnostics & Research | $1.0B | 58 |